Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry

Affiliations

• ¹ Department of Dermatology, University of California, San Francisco, California. Electronic address: Haley.Naik@ucsf.edu.
• ² Dermatology Division, Department of Medicine, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
• ³ Department of Dermatology, Liverpool Hospital, University of New South Wales, Sydney, Australia.
• ⁴ Hope for HS, Troy, Michigan.
• ⁵ Department of Neurology, Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
• ⁶ Division of Infection and Immunity, Department of Dermatology & Academic Wound Healing, Cardiff University, Cardiff, United Kingdom.
• ⁷ Department of Dermatology, University of California, San Francisco, California.
• ⁸ The Rockefeller University, New York, New York.
• ⁹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
• ¹⁰ Patientforeningen HS Danmark, Copenhagen, Denmark.
• ¹¹ HS Warriors, Port Richey, Florida.